Mylan gets FDA OK for new Duragesic dose |
|
|
|
Published
:
Wed, 31 Jan 2007 17:07
|
PITTSBURGH (AFX) - Drug maker Mylan Laboratories Inc. said Wednesday that the Food and Drug Administration approved the company's fifth strength of a line of generic pain patches marketed by Johnson & Johnson Inc.The FDA approved Mylan's 12 microgram per hour fentanyl transdermal system, a generic version of the Duragesic pain patch sold by J&J unit Ortho-McNeil.Mylan said it is the first generic drug maker to offer all five dosage strengths of the patch.The company said it will begin shipping the new dose immediately.Mylan shares fell 8 cents to $21.95 in morning trading on the New York Stock Exchange.Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Mylan Labs gets generic VoSpire FDA OK 